Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2000 1
2005 2
2007 1
2008 2
2009 1
2010 1
2011 1
2012 1
2016 2
2017 2
2019 3
2020 2
2021 1
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.
Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, Leslie RD. Buzzetti R, et al. Diabetes. 2020 Oct;69(10):2037-2047. doi: 10.2337/dbi20-0017. Epub 2020 Aug 26. Diabetes. 2020. PMID: 32847960 Free PMC article.
These individuals, at diagnosis, clinically resemble T2D patients by not requiring insulin treatment, yet they have immunogenetic markers associated with T1D. Such a slowly evolving form of autoimmune diabetes, described as latent autoimmune diabete
These individuals, at diagnosis, clinically resemble T2D patients by not requiring insulin treatment, yet they have immunogenetic markers as …
Atypical Diabetes and Management Considerations.
Patil SP. Patil SP. Prim Care. 2022 Jun;49(2):225-237. doi: 10.1016/j.pop.2021.11.003. Epub 2022 Apr 22. Prim Care. 2022. PMID: 35595479 Review.
Patients with latent autoimmune diabetes in adults constitute up to 12% of all patients with diabetes, and they share immunogenetic and phenotypic features of type 1 and type 2 diabetes mellitus. They are commonly misdiagnosed as having t …
Patients with latent autoimmune diabetes in adults constitute up to 12% of all patients with diabetes, an …
Treatment of Latent Autoimmune Diabetes in Adults: What is Best?
Hals IK. Hals IK. Curr Diabetes Rev. 2019;15(3):188-193. doi: 10.2174/1573399814666180716144429. Curr Diabetes Rev. 2019. PMID: 30009709 Review.
Latent Autoimmune Diabetes in Adults (LADA), although formally classified as Type 1 Diabetes (T1D), very often (at least in Western countries) appear clinically with Type 2 Diabetes (T2D)-like features as overweight and insulin resistance
Latent Autoimmune Diabetes in Adults (LADA), although formally classified as Type 1 Diabetes (T1D), very
Adult-onset autoimmune diabetes: current knowledge and implications for management.
Buzzetti R, Zampetti S, Maddaloni E. Buzzetti R, et al. Nat Rev Endocrinol. 2017 Nov;13(11):674-686. doi: 10.1038/nrendo.2017.99. Epub 2017 Sep 8. Nat Rev Endocrinol. 2017. PMID: 28885622 Review.
Adult-onset autoimmune diabetes is a heterogeneous disease that is characterized by a reduced genetic load, a less intensive autoimmune process and a mild metabolic decompensation at onset compared with young-onset type 1 diabetes mellitus (T1DM). ...S …
Adult-onset autoimmune diabetes is a heterogeneous disease that is characterized by a reduced genetic load, a less intensive …
Smoking, use of smokeless tobacco, HLA genotypes and incidence of latent autoimmune diabetes in adults.
Edstorp J, Wei Y, Ahlqvist E, Alfredsson L, Grill V, Groop L, Rasouli B, Sørgjerd EP, Thorsby PM, Tuomi T, Åsvold BO, Carlsson S. Edstorp J, et al. Diabetologia. 2023 Jan;66(1):70-81. doi: 10.1007/s00125-022-05763-w. Epub 2022 Jul 28. Diabetologia. 2023. PMID: 35900371 Free PMC article.
AIMS/HYPOTHESES: Smoking and use of smokeless tobacco (snus) are associated with an increased risk of type 2 diabetes. We investigated whether smoking and snus use increase the risk of latent autoimmune diabetes in adults (LADA) and elucidated p …
AIMS/HYPOTHESES: Smoking and use of smokeless tobacco (snus) are associated with an increased risk of type 2 diabetes. We investigate …
Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection.
Liao Y, Xiang Y, Zhou Z. Liao Y, et al. Front Med. 2012 Sep;6(3):243-7. doi: 10.1007/s11684-012-0201-y. Epub 2012 Jul 28. Front Med. 2012. PMID: 22843304 Review.
There are almost 97 million diabetic patients nationwide. Latent autoimmune diabetes in adults (LADA) is a subtype of autoimmune diabetes. ...Here, we aim to review and discuss the diagnostic criteria of latent autoimmune
There are almost 97 million diabetic patients nationwide. Latent autoimmune diabetes in adults (LADA) is a subty …
Current view of diagnosis and treatment of latent autoimmune diabetes in adults.
Urbanová J, Brunerová L, Malinovská J, Pelechová B, Koberová L, Brož J. Urbanová J, et al. Vnitr Lek. 2021 Spring;67(2):97-102. Vnitr Lek. 2021. PMID: 34074108 English.
Latent Autoimmune Diabetes in Adults (LADA) is an autoimmune disease arising at adulthood. LADA is characterized by a less intensive autoimmune process, slower progression and a mild metabolic decompensation at onset compared with young-o
Latent Autoimmune Diabetes in Adults (LADA) is an autoimmune disease arising at adulthood. LADA is charac
Sphingomyelin profiling in patients with diabetes could be potentially useful as differential diagnostics biomarker: A pilot study.
Sokołowska E, Car H, Fiedorowicz A, Szelachowska M, Milewska A, Wawrusiewicz-Kurylonek N, Szumowski P, Krzyżanowska-Grycel E, Popławska-Kita A, Żendzian-Piotrowska M, Chabowski A, Krętowski A, Siewko K. Sokołowska E, et al. Adv Med Sci. 2022 Sep;67(2):250-256. doi: 10.1016/j.advms.2022.06.001. Epub 2022 Jul 1. Adv Med Sci. 2022. PMID: 35785598 Free article.
PURPOSE: Autoimmune diabetes (AD) in adults includes both the classical form of type 1 diabetes mellitus (T1DM) and latent autoimmune diabetes in adults (LADA). ...Therefore, we determined sphingolipids in patients with newl …
PURPOSE: Autoimmune diabetes (AD) in adults includes both the classical form of type 1 diabetes mellitus (T1DM) …
Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists.
Giorgino F, Bonadonna RC, Gentile S, Vettor R, Pozzilli P. Giorgino F, et al. Diabetes Metab Res Rev. 2016 Sep;32(6):497-511. doi: 10.1002/dmrr.2775. Epub 2016 Mar 30. Diabetes Metab Res Rev. 2016. PMID: 26787264 Free PMC article. Review.
A substantial proportion of patients with type 2 diabetes mellitus do not reach glycemic targets, despite treatment with oral anti-diabetic drugs and basal insulin therapy. ...Current treatment guidelines will be summarized and discussed. 2016 The Authors. Diabet
A substantial proportion of patients with type 2 diabetes mellitus do not reach glycemic targets, despite treatment with oral anti-di …
GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MI. Niskanen LK, et al. Diabetes Care. 1995 Dec;18(12):1557-65. doi: 10.2337/diacare.18.12.1557. Diabetes Care. 1995. PMID: 8722051
OBJECTIVE: To study the frequency of antibodies to glutamic acid decarboxylase (GAD) and islet cell antibodies (ICAs) and their predictive value with respect to the development of insulin deficiency in 133 newly diagnosed middle-aged patients with non-insulin-dependent diabete
OBJECTIVE: To study the frequency of antibodies to glutamic acid decarboxylase (GAD) and islet cell antibodies (ICAs) and their predictive v …
24 results